9:22 AM
Leo Group India
| ||
| Par Pharmaceutical Shareholder Alert: The Briscoe Law Firm and Powers Taylor ... MarketWatch (press release) DALLAS, Jul 17, 2012 (BUSINESS WIRE) -- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Par Pharmaceutical Companies, Inc. ("PRX") ... See all stories on this topic » | ||
| Taro Pharmaceutical Shareholder, Guardian Point Capital, Issues Letter to Sun ... Sacramento Bee PRNewswire/ -- Guardian Point Capital, a minority shareholder of Taro Pharmaceutical Industries Ltd. (TARO), announced today that it delivered the following letter to Sun Pharmaceutical Industries Ltd. (SUNPHARMA.BO) in response to the proposal made by ... See all stories on this topic » | ||
| Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate ... MarketWatch (press release) SAN DIEGO, July 17, 2012 /PRNewswire via COMTEX/ -- Conatus Pharmaceuticals Inc. announced today the appointment of Daniel Ripley as Head of Corporate Development, effective immediately. Mr. Ripley will lead licensing, partnering initiatives, ... See all stories on this topic » | ||
| TPG to acquire US based Par Pharma for $1.9 billion pharmabiz.com TPG, a leading global private investment firm, has entered into an definitive agreement to acquire US based specialty pharmaceutical company, Par Pharmaceutical Companies, Inc. with an equity value of $1.9 billion. Under the terms of the agreement, Par ... See all stories on this topic » | ||
| Ironwood Pharmaceuticals Provides Second Quarter 2012 Investor Update MarketWatch (press release) Ironwood Pharmaceuticals (NASDAQ:IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood's guanylate cyclase-C agonist (GCCA), is an investigational drug for the treatment of ... See all stories on this topic » | ||
| CCL Industries Acquires Pharmaceutical Label Business in Sydney, Australia MarketWatch (press release) Graphitype's Pharmaceutical Division sales were AUD$7.3 million for the twelve-month period ending June 30, 2012, with EBITDA of approximately AUD$2.5 million. Dave and Kath Morris, the founders of Graphitype Printing Services, will continue to operate ... See all stories on this topic » | ||
| TPG picks up Par Pharmaceuticals Financial Times TPG, the private equity group, has acquired Par Pharmaceuticals for $1.9bn, marking the latest deal in the increasingly active healthcare sector. The acquisition is the third large deal since the US Supreme Court upheld the Obama administration's. See all stories on this topic » | ||
| Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and ... MarketWatch (press release) http://www.reportlinker.com/p0935311/Active-Pharmaceutical-Ingredients-API-Market-in-Europe-to-2017---Pricing-and-Reimbursement-Initiatives-Supporting-Generic-Drug-Growth-with-CMOs-Expected-to-Account-for-Majority-of-the-Manufacturing-Activity. See all stories on this topic » | ||
| Despite Deal With TPG, Speculation That Par Could Garner Higher Bids New York Times (blog) Shares of Par Pharmaceutical Companies surged more than 40 percent on Monday after the private equity firm TPG said it had reached a deal to acquire the firm for $1.9 billion, or $50 a share. But some in the industry believe that the TPG bid is below ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment